The neglected purpose of comparative-effectiveness research

New England Journal of Medicine

Volumn 360, Issue 19, 2009, Pages 1929-1931

  Naik, Aanand D ^a,c   Petersen, Laura A ^a,b,c  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Section of Health Services Research

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; FUNDING; GOVERNMENT; HEALTH CARE POLICY; HUMAN; INTERMETHOD COMPARISON; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE QUALITY; HEALTH SERVICES RESEARCH; LEGAL ASPECT; MANAGEMENT; MASS COMMUNICATION;

COST-BENEFIT ANALYSIS; DIFFUSION OF INNOVATION; FINANCING, GOVERNMENT; HEALTH POLICY; HEALTH SERVICES RESEARCH; HUMANS; POLICY MAKING; QUALITY OF HEALTH CARE;

EID: 65649154002     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp0902195     Document Type: Article

References (5)

1. Woolf SH. The meaning of translational research and why it matters. JAMA 2008;299:211-213
2. Alegria M. Academy Health 25th Annual Research Meeting chair address: from a science of recommendation to a science of implementation. Health Serv Res 2009;44:5-14.
3. Nallamothu BK, Bradley EH, Krumholz HM. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 2007;357:1631-1638 (Pubitemid 47598405)
4. Dougherty D, Conway PH. The "3T's" road map to transform US health care: the "how" of high-quality care. JAMA 2008;299:2319-2321
5. Naik AD, Issac TT, Street RL Jr, Kunik ME. Understanding the quality chasm for hypertension control in diabetes: a structured review of "co-maneuvers" used in clinical trials. J Am Board Fam Med 2007;20:469-478